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Small and modulated ﬁeld dosimetry is an active research area in modern radiotherapy. Current detectors perturb the mea-
surements due to their ﬁnite volume and lack of water equivalence. The selection of an appropriate detector can result in a
difﬁcult task, and usually several detectors are used to achieve a correct dose characterization. The development of new dosime-
try approaches and detectors is now a key point. High sensitivity and good spatial resolution are required in any detector for this
purpose. Spherical diodes of 1.8mm in diameter have been studied to assess their ability to perform dosimetric measurements
in radiotherapy high energy photon beams. The diodes were designed for the visible light energy spectrum but they have shown
a good response in brachytherapy energies (20–30keV). In this work they have been used to measure total scatter factors for
large and small ﬁelds (between 2 cm×2 cm and 18 cm×18 cm), comparing the results for the same setup measured with several
ionization chambers and planar diodes commercially available. A study about the change in diode response with the previous
irradiation, its angular response, and the possibility of correcting the overresponse to low energy scattered photons in large ﬁelds
by a metallic shielding layer was also done. Results show the feasibility of the spherical diode for relative dose measurements,
especially for small and modulated ﬁelds. Due to its high homogeneity in angular response compared to other detectors, they
can be employed for arc irradiations. They are also good candidates for in vivo dosimetry.
http://dx.doi.org/10.1016/j.rpor.2013.03.600
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Introduction. A Forward-planned multi segments technique (FPMS) is an alternative for situations when IMRT cannot be applied,
due to availability or to medical constrains. We believe this technique, applied by Lee for “head and neck” tumours, can be
applied to other areas, i.e. pelvic area, when reducing to the maximum the dosage in the intestine is critical. We are presenting
the results of a patient with endometrial carcinoma and previous history of peritoneal adhesion, where it was essential to reduce
the dosage in the intestine.
Material and methodology. To perform this technique, the outline of the nodal volumes is done using Small and col guidelines.
−Outline bowel − Plan using 15 isocentric ﬁelds. − Compare this dosimetry with a standard treatment in box and the machine
times.
Results. The dose in CTV is FPMS: V50 99.2% vs box: 98.1%. PTV: 47.50 99.2% vs 99.97%. On bowel for FPTS DM: 32.68Gy y box:
39.39Gy. The following cc were covered in each box. V Box FPTS DIFERENCIA V10 491,6 480,8 10,8 cc V20 458,5 419,2 39,3 cc V30
415,5 326,4 89,1 cc V40 302,5 197,5 105 cc V50 233,2 58,1 175,1 cc There is a bigger advantage for higher levels of dosage. The
treatment time required in a Siemens–Primus accelerator for FPMS is 6min and 2 s and for box is 2min and 25 s. This allows to
maintain comfortably the immobility required.
Conclusions. Considering timing, the treatment is feasible. The volume received by a 30Gy dosage in the bowel is 27% higher with
box. If we consider 40Gy, it is 53% higher with box.
http://dx.doi.org/10.1016/j.rpor.2013.03.601
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Introduction and objectives. Imaged guided radiotherapy (IGRT) allows as us to measure and correct the setup patient’s errors. In
this paper we estimate our margins for different locations based on the cone beam (CBCT) off line protocol patient corrections.
Methods. At our institution patient are treated in two Oncor Expression linacs (Siemens) with megavoltage CBCT based IGRT. We
analyze 474 patients with a total of 4821 CBCT, and classiﬁed the CBCT by tumor location: thorax, rectum, prostate, head & neck,
gynecological, abdomen. CTV to PTV margin is calculated from the random and systematic errors based on measurements in a
population of patients for each location, and these are estimated from the CBCT corrections performed in each patient (Sp). The
SD of the means per patient is an estimator for the systematic error for the population (˙ =SD(Si)p). The root mean square of
the SD’s of all patients patient is an estimator for the random error,  = raiz(<i2>p).
Results. and discussion CTV to PTV margin is calculated using Van Herk formula, Margin=2.5˙ +0.7. The margins obtained in
mm for each location (lateral, longitudinal, vertical) are: thorax (8, 7, 6), rectum (5, 5, 7), prostate (5, 4, 5), head&neck (5, 4, 4),
